Gin Hwa Biotech Incorporation (TPEX:7806)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
55.30
-0.80 (-1.43%)
At close: Oct 16, 2026

TPEX:7806 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
1,7841,7731,778--
Market Cap Growth
14.13%-0.27%---
Enterprise Value
1,9331,9571,938--
Last Close Price
55.3069.6267.89--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
27.8923.5326.63--
PS Ratio
3.333.294.09--
PB Ratio
2.302.293.76--
P/TBV Ratio
2.322.323.84--
P/OCF Ratio
14.0222.5025.21--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
3.613.634.45--
EV/EBITDA Ratio
18.9116.3817.71--
EV/EBIT Ratio
29.8521.3123.04--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.290.300.440.890.55
Debt / EBITDA Ratio
2.191.801.861.781.32
Debt / FCF Ratio
----0.94
Net Debt / Equity Ratio
0.190.150.190.650.25
Net Debt / EBITDA Ratio
1.590.950.831.390.80
Net Debt / FCF Ratio
-0.80-0.48-2.24-0.940.43
Asset Turnover
0.540.580.640.96-
Inventory Turnover
4.164.373.934.15-
Quick Ratio
0.911.561.980.860.83
Current Ratio
1.782.562.771.211.40
Return on Equity (ROE)
8.77%12.09%18.32%41.60%-
Return on Assets (ROA)
4.05%6.15%7.79%15.37%-
Return on Invested Capital (ROIC)
5.77%10.02%13.95%27.73%17.75%
Return on Capital Employed (ROCE)
7.20%9.80%13.00%27.00%21.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
3.12%4.25%3.75%--
FCF Yield
-10.54%-13.24%-2.29%--
Dividend Yield
1.72%1.57%1.34%--
Payout Ratio
42.84%31.67%11.16%7.79%33.43%
Buyback Yield / Dilution
-13.45%-11.72%-15.33%-48.94%-
Total Shareholder Return
-11.73%-10.15%-13.99%-48.94%-